loadpatents
name:-0.0345299243927
name:-0.032313108444214
name:-0.0017011165618896
Heavner; George Patent Filings

Heavner; George

Patent Applications and Registrations

Patent applications and USPTO patent grants for Heavner; George.The latest application filed is for "anti-il-12 antibodies, epitopes, compositions, methods and uses".

Company Profile
1.33.30
  • Heavner; George - Merrimack NH
  • Heavner; George - Malvern PA
  • Heavner; George - Malvem PA
  • Heavner; George - Radnor PA US
  • Heavner; George - Malrem PA
  • Heavner; George - Flemington NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses
App 20190085069 - Giles-Komar; Jill ;   et al.
2019-03-21
Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses
App 20180079809 - Giles-Komar; Jill ;   et al.
2018-03-22
Method of treating lupus by administering an anti-IL-12 antibody
Grant 9,862,766 - Giles-Komar , et al. January 9, 2
2018-01-09
Anti-TNF antibodies, compositions, methods and uses
Grant 9,828,424 - Heavner , et al. November 28, 2
2017-11-28
Method of Treating Lupus By Administering An Anti-IL-12 Antibody
App 20170157247 - Giles-Komar; Jill ;   et al.
2017-06-08
Nucleic acids encoding anti-IL-12 antibody
Grant 9,605,067 - Giles-Komar , et al. March 28, 2
2017-03-28
Anti-IL-12 Antibody Nucleic Acids and Methods
App 20160319014 - Giles-Komar; Jill ;   et al.
2016-11-03
Anti-tnf Antibodies, Compositions, Methods And Uses
App 20160264659 - Heavner; George ;   et al.
2016-09-15
Method of treating Crohn's disease by administering an anti-IL-12 antibody
Grant 9,428,579 - Giles-Komar , et al. August 30, 2
2016-08-30
Anti-TNF antibodies, compositions, methods and uses
Grant 9,321,836 - Heavner , et al. April 26, 2
2016-04-26
Method of Treating Crohn's Disease By Administering An Anti-IL-12 Antibody
App 20150030608 - Giles-Komar; Jill ;   et al.
2015-01-29
Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
Grant 8,894,990 - Giles-Komar , et al. November 25, 2
2014-11-25
Anti- Tnf Antibodies, Compositions, Methods And Uses
App 20140161816 - Heavner; George ;   et al.
2014-06-12
Melanocortin Receptor Binding Conjugates
App 20140050745 - Heavner; George
2014-02-20
Fusion proteins of alpha-MSH derivatives and Fc
Grant 8,614,185 - Heavner December 24, 2
2013-12-24
Anti-TNF antibodies, compositions, methods and uses
Grant 8,603,778 - Heavner , et al. December 10, 2
2013-12-10
Method for Treating Psoriatic Arthritis By Administering An Anti-IL-12 Antibody
App 20130129617 - Giles-Komar; Jill ;   et al.
2013-05-23
Method for treating psoriasis by administering an anti-IL-12 antibody
Grant 8,329,170 - Giles-Komar , et al. December 11, 2
2012-12-11
Anti- Tnf Antibodies, Compositions, Methods And Uses
App 20120282170 - Heavner; George ;   et al.
2012-11-08
Method for Treating Psoriasis by Administering An Anti-IL-12 Antibody
App 20120207670 - Giles-Komar; Jill ;   et al.
2012-08-16
Anti-TNF antibodies, compositions, methods and uses
Grant 8,241,899 - Heavner , et al. August 14, 2
2012-08-14
Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses
App 20120189627 - Heavner; George
2012-07-26
Anti-IL-12 antibodies
Grant 8,080,247 - Giles-Komar , et al. December 20, 2
2011-12-20
Melanocortin Receptor Binding Conjugates
App 20100278845 - Heavner; George
2010-11-04
Anti-TNF antibodies, compositions, methods and uses
Grant 7,820,169 - Heavner , et al. October 26, 2
2010-10-26
Anti-TNF antibodies, compositions, methods and uses
Grant 7,815,909 - Heavner , et al. October 19, 2
2010-10-19
Solution phase biopanning method using engineered decoy proteins
Grant 7,790,405 - O'Neil , et al. September 7, 2
2010-09-07
Anti-TNF antibodies, compositions, methods and uses
Grant 7,691,378 - Heavner , et al. April 6, 2
2010-04-06
Anti-TNF Antibodies, Compositions, Methods and Uses
App 20090252743 - Heavner; George ;   et al.
2009-10-08
Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses
App 20090202549 - Giles-Komar; Jill ;   et al.
2009-08-13
Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses
App 20090181037 - Heavner; George
2009-07-16
Anti-IL-12/23p40 Antibodies, Epitopes, Formulations, Compositions, Methods and Uses
App 20090181027 - Dal Monte; Paul ;   et al.
2009-07-16
Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
Grant 7,547,767 - Yang , et al. June 16, 2
2009-06-16
Anti-TNF antibodies, compositions, methods and uses
Grant 7,521,206 - Heavner , et al. April 21, 2
2009-04-21
Anti-tnf Antibodies, Compositions, Methods And Uses For Treatment Of Depression And Related Conditions
App 20090081234 - Heavner; George ;   et al.
2009-03-26
Anti-TNF Antibodies, Compositions, Methods and Uses
App 20090081241 - Heavner; George ;   et al.
2009-03-26
Anti-TNF Antibodies, Compositions, Methods and Uses
App 20090074794 - Heavner; George ;   et al.
2009-03-19
Anti-dual integrin antibodies, compositions, methods and uses
Grant 7,288,390 - Heavner , et al. October 30, 2
2007-10-30
Anti-TNF antibodies, compositions, methods and uses
Grant 7,250,165 - Heavner , et al. July 31, 2
2007-07-31
Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses
App 20070128200 - Yang; Jing ;   et al.
2007-06-07
Methods of Preparing Targeted Immunoliposomes
App 20070092558 - Heavner; George ;   et al.
2007-04-26
Anti-TNF antibodies, compositions, methods and uses
App 20070003548 - Heavner; George ;   et al.
2007-01-04
Method for generating monoclonal antibodies
App 20060246061 - MBow; M. Lamine ;   et al.
2006-11-02
Erythropoietin conjugate compounds with extended half-lives
Grant 7,074,755 - Heavner July 11, 2
2006-07-11
Solution phase biopanning method using engineered decoy proteins
App 20050239140 - O'neil, Karyn ;   et al.
2005-10-27
Anti-TNF antibodies, compositions, methods and uses
App 20050123541 - Heavner, George ;   et al.
2005-06-09
Erythropoietin conjugate compounds with extended half-lives
App 20040229318 - Heavner, George
2004-11-18
Method for generating monoclonal antibodies
App 20030235891 - MBow, M. Lamine ;   et al.
2003-12-25
Anti-TNF antibodies, compositions, methods and uses
App 20030049725 - Heavner, George ;   et al.
2003-03-13
Anti-dual integrin antibodies, compositions, methods and uses
App 20030040044 - Heavner, George ;   et al.
2003-02-27
Tetra and penta-peptides useful in regulating the immune system
Grant 5,298,490 - Heavner , et al. March 29, 1
1994-03-29
B cell differentiating peptides and conjugates thereof
Grant 4,866,121 - Audhya , et al. * September 12, 1
1989-09-12
B-cell differentiating peptides
Grant 4,783,442 - Audhya , et al. * November 8, 1
1988-11-08
Conformationally restricted thymopentin-like compounds
Grant 4,547,489 - Goldstein , et al. October 15, 1
1985-10-15
Enzyme-resistant immunomodulatory peptides
Grant 4,505,853 - Goldstein , et al. March 19, 1
1985-03-19
Peptides having thymopoietin-like activity
Grant 4,397,842 - Goldstein , et al. August 9, 1
1983-08-09
N-Protected pentapeptides useful as intermediates in the preparation of thymopoietin pentapeptide
Grant 4,369,137 - Heavner January 18, 1
1983-01-18
Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
Grant 4,298,523 - Heavner November 3, 1
1981-11-03
Immunoregulatory diketopiperazine compounds
Grant 4,289,759 - Heavner , et al. September 15, 1
1981-09-15
Method and composition for preparation of H-SAR-LYS-SAR-GLN-NH.sub.2
Grant 4,250,086 - Heavner February 10, 1
1981-02-10
Peptides having ubiquitin-like activity
Grant 4,215,111 - Goldstein , et al. July 29, 1
1980-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed